Tissue adhesive
Patent 4298598 Issued on November 3, 1981. Estimated Expiration Date: 
February 4, 2000. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 4, 2000. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorsApplicationNo. 06/118656 filed on 02/04/1980US Classes:424/94.64, Serene proteinases (3.4.21) (e.g., trypsin, chymotrypsin, plasmin, thrombin, elastase, kallikrein, fibrinolysin, streptokinease, etc.)514/2, Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI514/21, Produced by or extracted from animal tissue514/8Glycoprotein (carbohydrate containing)ExaminersPrimary: Cacciapaglia, Frank Jr.Attorney, Agent or FirmInternational ClassesA61L 24/00 (20060101)A61L 24/10 (20060101) Foreign Application Priority Data1979-02-15 ATAbstractA tissue adhesive on the basis of human or animal proteins has a content of factor XIII and fibrinogen, the ratio of factor XIII to fibrinogen, expressed in units of factor XIII per gram of fibrinogen, amounting to at least 80. Furthermore, it contains a plasminogen-activator-inhibitor or plasmin-inhibitor in an amount of 20 to 2,000 KIU per ml.Other References
| |
